New York is experiencing a boom in new hemp farms as the CBD oil industry has grown rapidly.
But without guidance from the U.S. Food and Drug Administration, the industry can’t reach its potential, Sen. Charles Schumer warned Tuesday.
Schumer urged the FDA to complete its review of the safety of the popular cannabidiol market and also issue regulations to protect consumers.
So far, federal regulators have only approved medical grade CBD for treating severe epilepsy and instead have handled other CBD products similar to nutritional supplements that get limited FDA scrutiny.
This content is brought to you by the FingerLakes1.com Team. Support our mission by visiting www.patreon.com/fl1 or learn how you send us your local content here.